CNS Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
365
across all filing types
Latest filing
2026-05-04
Regulatory Filings
Country
US
United States of America
Listing
US
CNSP
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that develops anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company's primary focus is on glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. Its lead drug candidate, Berubicin, is an anthracycline designed to cross the blood-brain barrier, a significant challenge in treating CNS tumors. The company's technology aims to enable therapeutics to penetrate the brain and directly target tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - CNS Pharmaceuticals, Inc. (0001729427) (Filer) | 2026-05-04 | English | |
| 4 - CNS PHARMACEUTICALS, INC. (0001729427) (Filer) | 2026-03-04 | English | |
| 4 - CNS PHARMACEUTICALS, INC. (0001729427) (Filer) | 2026-03-04 | English | |
| 8-K - CNS PHARMACEUTICALS, INC. (0001729427) (Filer) | 2026-03-02 | English | |
| 8-K Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 40872218 | 8-K - CNS Pharmaceuticals, Inc. (0001729427) (Filer) | 2026-05-04 | English | ||
| 32897381 | 4 - CNS PHARMACEUTICALS, INC. (0001729427) (Filer) | 2026-03-04 | English | ||
| 32897382 | 4 - CNS PHARMACEUTICALS, INC. (0001729427) (Filer) | 2026-03-04 | English | ||
| 32897383 | 8-K - CNS PHARMACEUTICALS, INC. (0001729427) (Filer) | 2026-03-02 | English | ||
| 31509598 | 8-K Filing | 2026-02-17 | English | ||
| 31509455 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 13090946 | Director's Dealing 2026 | 2026-01-02 | English | ||
| 13090981 | Director's Dealing 2026 | 2026-01-02 | English | ||
|
2025
7 filings
| |||||
| 13090962 | CURRENT REPORT | 2025-12-17 | English | ||
| 13090947 | CURRENT REPORT | 2025-11-21 | English | ||
| 13090984 | Director's Dealing 2025 | 2025-11-19 | English | ||
| 13090948 | Director's Dealing 2025 | 2025-11-19 | English | ||
| 13090949 | Director's Dealing 2025 | 2025-11-19 | English | ||
| 13090950 | Director's Dealing 2025 | 2025-11-19 | English | ||
| 13090985 | Director's Dealing 2025 | 2025-11-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
CNS Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35399/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35399 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35399 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35399 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35399}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CNS Pharmaceuticals, Inc. (id: 35399)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.